These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8703799)

  • 1. The place of blood stem cells in allogeneic transplantation.
    Russel N; Gratwohl A; Schmitz N
    Br J Haematol; 1996 Jun; 93(4):747-53. PubMed ID: 8703799
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid and sustained allogeneic transplantation using immunoselected CD34(+)-selected peripheral blood progenitor cells mobilized by recombinant granulocyte- and granulocyte-macrophage colony-stimulating factors.
    Corringham RE; Ho AD
    Blood; 1995 Sep; 86(5):2052-4. PubMed ID: 7544651
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic transplantation of peripheral blood progenitor cells.
    Link H; Arseniev L
    Ann Oncol; 1996; 7 Suppl 2():41-5. PubMed ID: 8805948
    [No Abstract]   [Full Text] [Related]  

  • 4. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous stem cell transplantation: exogenous granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor modulate the endogenous cytokine levels.
    Testa U; Martucci R; Scambia G; Panici PB; Mancuso S; Camagna A; Mastroberardino G; Pierelli L; Menichella G; Peschle C
    Blood; 1997 Apr; 89(7):2615-7. PubMed ID: 9116312
    [No Abstract]   [Full Text] [Related]  

  • 6. Peripheral blood progenitor cells: a replacement for marrow transplantation?
    Champlin RE
    Semin Oncol; 1996 Apr; 23(2 Suppl 4):15-21. PubMed ID: 8600543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies.
    Sohn SK; Jung JT; Kim DH; Lee NY; Seo KW; Chae YS; Park SW; Kim JG; Suh JS; Lee KB
    Cancer; 2002 Jan; 94(1):18-24. PubMed ID: 11815956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-mobilized peripheral blood progenitor cells.
    Nemunaitis J
    Semin Oncol; 1996 Apr; 23(2 Suppl 4):9-14. PubMed ID: 8600547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony-stimulating factor increases the proportion of circulating dendritic cells after autologous but not after allogeneic hematopoietic stem cell transplantation.
    Eksioglu EA; Kielbasa J; Eisen S; Reddy V
    Cytotherapy; 2011 Aug; 13(7):888-96. PubMed ID: 21609205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Graft of blood stem cells].
    Reiffers J
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):291-2. PubMed ID: 7687775
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral blood progenitor cell (PBPC) transplantation with a single apheresis in various malignancies.
    Efremidis AP; Koumakis G; Filis J; Moraki M; Vassilomanolakis M; Barbounis V; Hatzichristou H; Papanastasiou K; Stamatellou M
    Bone Marrow Transplant; 1996 Apr; 17(4):673-4. PubMed ID: 8722374
    [No Abstract]   [Full Text] [Related]  

  • 12. Mobilization, purification and ex vivo expansion of human peripheral blood progenitor cells.
    Brugger W; Mertelsmann R; Kanz L
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):221-3. PubMed ID: 7687768
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
    Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
    J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-hodgkin's lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF.
    Gazitt Y; Akay C; Thomas C
    Stem Cells Dev; 2006 Apr; 15(2):269-77. PubMed ID: 16646673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological characteristics of cells migrating into the bloodstream.
    Testa NG
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S12-3. PubMed ID: 8722326
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of exogenous recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following allogeneic bone marrow transplantation.
    Fabian I; Kletter Y; Bleiberg I; Gadish M; Naparsteck E; Slavin S
    Exp Hematol; 1991 Oct; 19(9):868-73. PubMed ID: 1716591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic growth factors for the mobilization of peripheral blood stem cells.
    Haas R; Hohaus S; Goldschmidt H; Witt B; Hunstein W
    J Hematother; 1993; 2(3):357-9. PubMed ID: 7522890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor mobilizes more dendritic cell subsets than granulocyte-macrophage colony-stimulating factor with no polarization of dendritic cell subsets in normal donors.
    Shaughnessy PJ; Bachier C; Lemaistre CF; Akay C; Pollock BH; Gazitt Y
    Stem Cells; 2006 Jul; 24(7):1789-97. PubMed ID: 16822885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilization of peripheral blood progenitor cells for allogeneic transplantation.
    Teshima A; Harada M
    Cytokines Cell Mol Ther; 1997 Jun; 3(2):101-14. PubMed ID: 9287249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.